Cargando…
Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
Exacerbations in chronic obstructive pulmonary disease (COPD), which tend to occur in clusters and increase with disease severity, come with high societal and economic burdens. Prevention and delay of recurrent exacerbations is an unmet and significant therapeutic need for patients with COPD. GALATH...
Autores principales: | Singh, Dave, Criner, Gerard J, Agustí, Alvar, Bafadhel, Mona, Söderström, Johan, Luporini Saraiva, Gabriela, Song, Yue, Licaj, Idlir, Jison, Maria, Martin, Ubaldo J, Psallidas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390712/ https://www.ncbi.nlm.nih.gov/pubmed/37533773 http://dx.doi.org/10.2147/COPD.S418944 |
Ejemplares similares
-
Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab
por: Menzies-Gow, Andrew, et al.
Publicado: (2022) -
A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
por: Menzies-Gow, Andrew, et al.
Publicado: (2022) -
Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria
por: Magen, Eli, et al.
Publicado: (2022) -
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021) -
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
por: Bafadhel, Mona, et al.
Publicado: (2022)